Literature DB >> 21794997

Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions.

Alexander W Sauter1, Anne Merkle, Maximilian Schulze, Daniel Spira, Juergen Hetzel, Claus D Claussen, Marius S Horger.   

Abstract

OBJECTIVES: To evaluate intraobserver and interobserver agreement of manually encompassed lung lesions for perfusion measurements using volume-perfusion computed tomography (VPCT).
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. HIPAA guidelines were followed. A 65-s dynamic study was acquired with scan parameters 80 kV, 60 mAs (80 mAs for patients ≥ 70 kg), 128 × 0.6mm collimation. Blood flow (BF), blood volume (BV) and K(trans) parameters were determined by syngo volume perfusion CT body with 88 lesions analyzed retrospectively.
RESULTS: Within-subject coefficients of variation for intraobserver agreement (range 6.59-12.82%) were superior to those for interobserver agreement (range 21.75-38.30%). Size-dependent analysis revealed lower agreements for lesions <4 cm as compared to larger lesions. Additionally, agreements of the upper, middle and lower lung zones were different.
CONCLUSIONS: Intraobserver agreement was substantial for VPCT lung cancer perfusion measurements encouraging the use for tumor characterization and therapy response monitoring. Interobserver agreement is limited and unexperienced readers should be trained before using this new method.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21794997     DOI: 10.1016/j.ejrad.2011.06.047

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Authors:  R Syha; L Grünwald; T Horger; D Spira; D Ketelsen; W Vogel; C D Claussen; M Horger
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

2.  Functional CT imaging techniques for the assessment of angiogenesis in lung cancer.

Authors:  Thomas Henzler; Jingyun Shi; Hashim Jafarov; Stefan O Schoenberg; Christian Manegold; Christian Fink; Gerald Schmid-Bindert
Journal:  Transl Lung Cancer Res       Date:  2012-03

3.  Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.

Authors:  Jill Rachel Mains; Frede Donskov; Erik Morre Pedersen; Hans Henrik Torp Madsen; Jesper Thygesen; Kennet Thorup; Finn Rasmussen
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

Review 4.  State of the art: Response assessment in lung cancer in the era of genomic medicine.

Authors:  Mizuki Nishino; Hiroto Hatabu; Bruce E Johnson; Theresa C McLoud
Journal:  Radiology       Date:  2014-04       Impact factor: 11.105

5.  Intra-observer and inter-observer agreements for the measurement of dual-input whole tumor computed tomography perfusion in patients with lung cancer: Influences of the size and inner-air density of tumors.

Authors:  Qingle Wang; Zhiyong Zhang; Fei Shan; Yuxin Shi; Wei Xing; Liangrong Shi; Xingwei Zhang
Journal:  Thorac Cancer       Date:  2017-06-06       Impact factor: 3.500

6.  Can visual assessment of blood flow patterns by dynamic contrast-enhanced computed tomography distinguish between malignant and benign lung tumors?

Authors:  Stefan Walbom Harders; Hans Henrik Madsen; Hanne Marie Nellemann; Torben Riis Rasmussen; Jesper Thygesen; Henrik Hager; Niels Trolle Andersen; Finn Rasmussen
Journal:  Acta Radiol Open       Date:  2017-05-30

7.  CT perfusion imaging can detect residual lung tumor early after radiofrequency ablation: a preliminary animal study on both tumoral and peri-tumoral region assessment.

Authors:  Zenghui Cheng; Yixue Wang; Min Yuan; Jianxiao Liang; Yanling Feng; Yuxin Shi; Zhiyong Zhang; Fei Shan
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 2.895

8.  Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.

Authors:  Tobias Lahmer; Wolfgang Huber; Sebastian Rasch; Paul Schmidle; Sengül Sancak; Alexander Herner; Christina Huberle; Dominik Schulz; Ulrich Mayr; Jochen Schneider; Christoph D Spinner; Fabian Geisler; Roland M Schmid
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

Review 9.  Functional imaging in lung cancer.

Authors:  S W Harders; S Balyasnikowa; B M Fischer
Journal:  Clin Physiol Funct Imaging       Date:  2013-12-01       Impact factor: 2.273

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.